Huma has now launched a building block customers can ship:
AI-powered transcription of clinical consultations, forming structured, usable data, making regulated AI workflows easier to deploy at scale.

After a decade of continuous real-world observation, Huma’s regulated research infrastructure enabled the VARGADO study to translate longitudinal oncology data into durable, peer-reviewed evidence at clinical scale.

Powered by Huma’s platform, HANSE validates PLCOm2012 for nationwide adoption, forming Germany’s 2026 lung cancer screening blueprint.

Huma’s regulated, disease-agnostic platform powers Idorsia’s non-interventional ProDiGy study, generating real-world evidence on insomnia treatment across Germany and Austria.

Huma’s regulated, disease-agnostic platform powers a real-world data investigation modernising neonatal and pediatric critical care.

Huma eTriage deployed in a leading London NHS Emergency Department, with the Huma Cloud Platform unifying fragmented systems into a single, regulated, AI-driven care flow at scale.

Huma’s regulated platform enables organisations to build AI-driven healthcare software across 70+ countries, demonstrating that true clinical scale depends on trusted, regulated AI.

4,500 patients recruited a full year ahead of schedule — setting the stage for breakthrough insights to improve kidney and diabetes care worldwide

Three years since Homerton’s pioneering launch, the partnership is renewed and growing stronger

Neuromuscular feedback in Paraplegia Care – the latest clinical trial study powered by Huma